A list of 23 medications with subpar quality was published by the health department′s food safety and drug control commissioner (FSDCC).

According to an FSDCC order, these medications should no longer be used, and the available stock should be withdrawn in accordance with the 1940 Drugs and Cosmetics Act to provide consumers with an adequate level of protection.

These poor-quality medications were manufactured in companies located in Jaipur, Dholpur, and Alwar in Rajasthan; Solon in Himachal Pradesh; Roorkee in Uttar Pradesh; and Surendranagar in Gujarat.

The majority of the samples were deemed unsatisfactory because they did not support the claims made on the medications′ packaging. 11 of the 23 samples included menthol syrup, ammonium chloride, sodium citrate, and chlorpheniramine maleate, which contradicted the claim made in the menthol assay (an analysis used to determine whether or not a substance is present in a medicine). Three of these eleven samples were manufactured by Kaysons Pharma in Jaipur, and the remaining eight were produced by Navkar Lifesciences in Solon, Himachal Pradesh.

FSDCC officials regularly collect samples of medications for quality control to guarantee that patients receive medicines that will benefit them and provide relief.

(Source: https://timesofindia.indiatimes.com/city/jaipur/23-drugs-are-of-poor-quality-health-dept/articleshowprint/96072327.cms?val=3728)